GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
Rating: LLY
Overweight $95

Eli Lilly And Company (NYSE: LLY) upgraded to Overweight with price target $95 by Barclays

Tuesday,  Dec 1, 2015  1:25 PM ET by Dave Ficere

Barclays upgraded Eli Lilly And Company (NYSE: LLY) to Overweight with price
target $95. Previously Barclays rated Equal Weight with price target $75 Eli Lilly And Company (NYSE: LLY) on 07/22/2015, when the stock price was $85.70.

Eli Lilly and Company discovers, develops, manufactures, and sells products in one significant business segment -pharmaceutical products. The company directs its research efforts primarily toward the search for products to diagnose, prevent and treat human diseases. The company also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

Barclays



RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy